Eurofins Viracor is a leader in diagnostic testing with over 30 years of innovation and expertise, specializing in infectious diseases, allergy and immunology, as well as pre- and post-transplant testing targeted at immunocompromised and critically ill patients. The brand offers an extensive menu of over 3,000 assays designed to improve patient outcomes through timely and accurate diagnostic information.

Their commitment to quality and innovation ensures that each test is meticulously designed to reduce false negatives. By employing dual-gene targets in their qPCR assays, Eurofins Viracor can effectively detect multiple strains, minimizing the risk of missed diagnoses. Their dedication to compliance ensures that all services meet stringent regulatory standards, underscoring their mission of enhancing patients' lives through reliable laboratory services.

With a focus on collaboration and open communication, Eurofins Viracor empowers healthcare providers by delivering actionable insights that make informed decisions possible, affirming their vision as a trusted partner in the healthcare landscape.